{"nct_id":"NCT01114503","title":"A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease","status":"TERMINATED","status_verified_date":"2020-10","start_date":"2010-07-07","start_date_type":"ACTUAL","primary_completion_date":"2012-08-29","primary_completion_date_type":"ACTUAL","completion_date":"2012-08-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}